Your browser doesn't support javascript.
loading
Prophylactic Left Atrial Appendage Exclusion in Cardiac Surgery Patients With Elevated CHA2DS2-VASc Score: Results of the Randomized ATLAS Trial.
Gerdisch, Marc W; Garrett, H Edward; Mumtaz, Mubashir A; Grehan, John F; Castillo-Sang, Mario; Miller, Jeffrey S; Zorn, George L; Gall, Stanley A; Johnkoski, John A; Ramlawi, Basel.
Affiliation
  • Gerdisch MW; Franciscan Health Indianapolis, IN, USA.
  • Garrett HE; Cardiovascular Surgery Clinic, Memphis, TN, USA.
  • Mumtaz MA; University of Pittsburgh Medical Center Central PA, Harrisburg, PA, USA.
  • Grehan JF; Allina Health System, St. Paul, MN, USA.
  • Castillo-Sang M; The Christ Hospital, Cincinnati, OH, USA.
  • Miller JS; Emory University Hospital, Atlanta, GA, USA.
  • Zorn GL; University of Kansas Medical Center, Kansas City, KS, USA.
  • Gall SA; CVA Heart Institute, Kingsport, TN, USA.
  • Johnkoski JA; Aspirus Wausau Hospital, WI, USA.
  • Ramlawi B; Lankenau Heart Institute, Philadelphia, PA, USA.
Innovations (Phila) ; 17(6): 463-470, 2022.
Article in En | MEDLINE | ID: mdl-36373654
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Atrial Fibrillation / Atrial Appendage / Stroke / Cardiac Surgical Procedures Type of study: Clinical_trials Limits: Adolescent / Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Atrial Fibrillation / Atrial Appendage / Stroke / Cardiac Surgical Procedures Type of study: Clinical_trials Limits: Adolescent / Humans Language: En Year: 2022 Type: Article